The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenture Life Regulatory News (VLG)

Share Price Information for Venture Life (VLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.75
Bid: 40.00
Ask: 41.50
Change: 0.25 (0.62%)
Spread: 1.50 (3.75%)
Open: 40.20
High: 40.75
Low: 40.20
Prev. Close: 40.50
VLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

6 Jan 2020 15:38

RNS Number : 8950Y
Venture Life Group PLC
06 January 2020
 

6 January 2020

 

Venture Life Group plc

("Venture Life" or the "Company")

Grant of Options

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the self-care market, announces that it has granted further share options ("Options") over ordinary shares of 0.3 pence each in the capital of the Company ("Ordinary Shares").

On 6 January 2020 (the "Date of Grant"), Venture Life granted Options over a total of 4,000,000 Ordinary Shares to its four Executive Directors at a strike price of 33.7 pence per share, being the average of the closing market price on the five business days starting 19 December 2019. Vesting of the Options is subject to continued employment. The Options will vest in equal tranches on the following dates: 31 March 2020, 31 March 2021 and 31 March 2022.

Director

Position

Number of Options in this grant

Jerry Randall

Chief Executive Officer

 1,000,000

Gianluca Braguti

Chief Manufacturing Officer

 1,000,000

Sharon Collins

Chief Commercial Officer

 1,000,000

Andrew Waters

Chief Financial Officer

 1,000,000

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail. 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.)

Names

1. Jerry Randall

2. Gianluca Braguti

3. Sharon Collins

4. Andrew Waters

2.

Reason for the notification

a.)

Position/status

1. Chief Executive Officer

2. Chief Manufacturing Officer

3. Chief Commercial Officer

4. Chief Financial Officer

b.)

Initial notification /Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.)

Name

Venture Life Group PLC

b.)

LEI

213800S8CZUPLAB2KC70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.)

Description of the financial instrument, type of instrument

Options over Ordinary Shares of 0.3 pence each in Venture Life Group plc

b.)

Identification code

GB00BFPM8908

c.)

Nature of the transaction

Grant of Options over Ordinary Shares

d.)

Price and volumes

 

Price

Volume

1. 33.7 pence

2. 33.7 pence

3. 33.7 pence

4. 33.7 pence

1. 1,000,000

2. 1,000,000

3. 1,000,000

4. 1,000,000

 

 

e.)

Aggregated information

- Aggregated volume

- Price

 

n/a

f.)

Date of the transaction

6 January 2020

g.)

Place of the transaction

Outside a trading venue

 

For further information please contact: 

Venture Life Group PLC

+44 (0) 1344 578 004

Jerry Randall, Chief Executive Officer

Andrew Waters, Chief Financial Officer

 

Cenkos (Nominated Adviser and Joint Broker)

+44 (0) 207 397 8900

Mark Connelly / Stephen Keys / Cameron MacRitchie (Corporate Finance) / Russell Kerr / Michael Johnson (Sales)

Alma PR

venturelife@almapr.com or +44 (0) 203 405 0208

Helena Bogle/Hilary Buchanan/Jessica Joynson

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFVELRIRIII
Date   Source Headline
10th May 202211:31 amRNSExercise of Share Options & Voting Rights
19th Apr 20227:00 amRNSReporting Update
23rd Mar 20223:00 pmRNSAnnouncement re: Full year results
22nd Feb 20227:00 amRNSGrant of Options and PDMR Dealing
21st Feb 20227:00 amRNSResults - clinical trial led by Cardiff University
31st Jan 20224:41 pmRNSSecond Price Monitoring Extn
31st Jan 20224:37 pmRNSPrice Monitoring Extension
31st Jan 20222:06 pmRNSSecond Price Monitoring Extn
31st Jan 20222:01 pmRNSPrice Monitoring Extension
31st Jan 20227:00 amRNSTrading Statement
24th Jan 20222:06 pmRNSSecond Price Monitoring Extn
24th Jan 20222:00 pmRNSPrice Monitoring Extension
10th Jan 20227:00 amRNSBusiness Update
29th Dec 202112:34 pmRNSDirector/PDMR Shareholding
20th Dec 20214:13 pmRNSDirectorate Change
14th Dec 202111:05 amRNSSecond Price Monitoring Extn
14th Dec 202111:01 amRNSPrice Monitoring Extension
3rd Dec 20214:22 pmRNSDirector/PDMR Shareholding
1st Dec 20219:06 amRNSSecond Price Monitoring Extn
1st Dec 20219:00 amRNSPrice Monitoring Extension
1st Dec 20217:00 amRNSTrading Update & Board Changes
1st Nov 20212:00 pmRNSPrice Monitoring Extension
1st Nov 20218:44 amRNSHolding(s) in Company
1st Nov 20218:43 amRNSHolding(s) in Company
25th Oct 20217:00 amRNSHolding(s) in Company
11th Oct 20212:41 pmRNSHolding(s) in Company
23rd Sep 20219:05 amRNSSecond Price Monitoring Extn
23rd Sep 20219:00 amRNSPrice Monitoring Extension
23rd Sep 20217:00 amRNSHalf-year Report
7th Sep 20211:54 pmRNSHolding(s) in Company
13th Aug 20219:05 amRNSSecond Price Monitoring Extn
13th Aug 20219:00 amRNSPrice Monitoring Extension
13th Aug 20217:00 amRNSTrading Update and Progress on recent Acquisitions
6th Aug 20217:00 amRNSAcquisition of Oncology Support Product Assets
21st Jun 20217:00 amRNSRevolving Credit Facility
7th Jun 20217:00 amRNSAcquisition of BBI Healthcare Limited
20th May 20212:29 pmRNSResult of AGM
14th Apr 20214:19 pmRNSHolding(s) in Company
25th Mar 20212:19 pmRNSConfirmation of AGM Date
25th Mar 20217:00 amRNSFinal Results
25th Feb 20217:00 amRNSInvestor Presentation
1st Feb 20217:00 amRNSTrading Update & Notice of Results
14th Dec 20202:07 pmRNSIssue of Equity
11th Dec 20207:27 amRNSHolding(s) in Company
10th Dec 20204:45 pmRNSHolding(s) in Company
10th Dec 20204:41 pmRNSHolding(s) in Company
10th Dec 20202:42 pmRNSHolding(s) in Company
10th Dec 20201:45 pmRNSHolding(s) in Company
9th Dec 20202:28 pmRNSDirector/PDMR Shareholding
8th Dec 202012:00 pmRNSResult of General Meeting and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.